Ingredient Considerations in Compounding Flashcards

1
Q

DEFINITION

pertains to the preparation of medications and is also included in the dispensing process

A

extemporaneous compounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DEFINITION

practice of preparation of a therapeutic product by mixing and combining pharmaceutical agents for an individual patient in response to the identified need

A

extemporaneous compounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the other cases in which extemporaneous compounding is needed?

A
  1. if px is allergic to a certain excipient
  2. if px has dysphagia (difficulty in swallowing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two types of extemporaneous compounding?

A
  1. simple
  2. complex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DEFINITION

extemporaneous compounding that requires 1 API

A

simple

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DEFINITION

extemporaneous compounding that requires 2 or more APIs

A

complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the potency to be considered acceptable for USP-NF?

A

API potency of 80% and above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

FCC stands for?

A

Food Chemical Codex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the chemical grade with the highest purity?

A

analytical grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T/F: reagent grade can be taken orally or parenterally

A

F - cannot be taken PO or parenterally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SOURCES OF INGREDIENTS

What are the recommended or standardized sources of ingredients for compounding all drug preparations?

A

USP, NF or FCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SOURCES OF INGREDIENTS

Alternative high-quality source such as __________________________ or
certified _______________________ grade may be considered applying professional judgement

A

analytical reagent (AR) or certified American Chemical Society (ACS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SOURCES OF INGREDIENTS

T/F: Only manufactured drug products from containers labeled with a batch control number and a future expiration date are acceptable as potential source of active ingredients

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SOURCES OF INGREDIENTS

used when receiving raw materials to assure quality of material received for manufacture

A

certificate of analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SOURCES OF INGREDIENTS

when compounding with ______________________ products, all ingredients present in the drug product must be considered relative to the _______________________ of the compounded preparation

A

manufacture drug; intended use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the special considerations in compounding?

A

compounding with…
1. hydrates and solvates
2. inorganic salts
3. organic salts
4. esters
5. aliquots, dilutions, & concentrates
6. potency-designated ingredients
7. complex organic molecules
8. commercial products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hours of stability of high-risk compounded products

A

24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

COMPOUNDING WITH HYDRATES AND SOLVATES

T/F: The more molecules of water present in the molecule, the less of the chemical should be weighed to obtain the actual active drug.

A

F - more of the chemical should be weighed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

T/F: if water adds to the total weight, it is considered overdosage

A

F - underdosage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PACKAGING OF HYDRATES AND SOLVATES

Why must these products be packaged in tight containers?

A

to prevent the loss or gain of moisture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

STORAGE OF HYDRATES AND SOLVATES

What is the importance of storing these products at the indicated temperatures?

A

to minimize exposure to high humidity levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the required %humidity in the compounding area?

A

less than 60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

compounds that lose water in their molecules and may become powdery when exposed to air

A

efflorescent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

compounds that gain water in their molecules or absorb water but remain solid

A

hygroscopic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
compounds that absorb water and liquefies
deliquescent
26
COMPOUNDING WITH INORGANIC SALTS What are the characteristics of inorganic salts that affect their physical and chemical properties?
1. particle size 2. tendency to absorb or give off water 3. pH
27
COMPOUNDING WITH INORGANIC SALTS _______________ properties of the compound should be considered
solubility
28
COMPOUNDING WITH INORGANIC SALTS Acid salts corresponding to an insoluble salt will be _________________ than the original salt
more water soluble
29
COMPOUNDING WITH INORGANIC SALTS __________________ are water-insoluble, except for their alkali metal salts
Sulfides
30
COMPOUNDING WITH INORGANIC SALTS most products are combined with salts to increase _______________ and become readily _____________ by the body (e.g., Losartan mixed with Potassium)
solubility; absorbed
31
COMPOUNDING WITH INORGANIC SALTS smaller particles have ___________ surface area
higher
32
examples of inorganic salts
NaCl, KCl, CaCO3
33
COMPOUNDING WITH ORGANIC SALTS Many drugs are _______, and the dose may be based on the ______________ form or just the ________ form of the drug
salts; total salt form; base form
34
COMPOUNDING WITH ORGANIC SALTS _______________________, USP, are based on the “albuterol” content (present as sulfate form)
Albuterol Sulfate Tablets
35
COMPOUNDING WITH ORGANIC SALTS _________________________________, USP, are based on the total molecule
Diphenhydramine Hydrochloride Capsules
36
COMPOUNDING WITH ORGANIC SALTS Drugs that are either weak acids or weak bases and have limited water solubility are often used as their “salts” form for what purpose?
to increase aqueous solubility
37
COMPOUNDING WITH ORGANIC SALTS What are the other uses of salt forms?
1. to enhance stability 2. to change other attributes of the drug to aid handling during compounding
38
COMPOUNDING WITH ORGANIC SALTS acids mixed with bases would yield water and salts that would cause ___________
precipitation
39
COMPOUNDING WITH ESTERS __________ prepared for solubility and stability purposes, to enhance resistance to degradation after administration and for use as prodrugs
esters
40
COMPOUNDING WITH ESTERS Drugs that form a precipitate upon injection may cause what?
pain at the site of injection and damage to the surrounding tissue
41
COMPOUNDING WITH ESTERS pain at the site of injection caused by drug precipitate formation may be overcome by?
preparing a drug with increased solubility
42
COMPOUNDING WITH ESTERS example of an ester drug preparation
Chloramphenicol succinate
43
COMPOUNDING WITH ESTERS T/F: Since some drugs may occur in salt forms, ester forms, and/or salt-ester forms, it is important to document what form is used and whether it is a salt, ester, or combination
T
44
COMPOUNDING WITH ESTERS examples of salts
Erythromycin estolate & Erythromycin stearate
45
COMPOUNDING WITH ESTERS example of an ester
Erythromycin ethylsuccinate
46
Reasons for preparing aliquots, dilutions and concentrates:
summarized answer: 1. quantities required are too small for accurate weighing 2. some are explosive and must be diluted 3. many substances are commercially available in percentage strengths that vary from one acid to another
47
What is a possible incompatibility when acids and bases are mixed?
precipitation
48
COMPOUNDING WITH POTENCY-DESIGNATED INGREDIENTS Some antibiotics, endocrine products, biotechnology-derived products, and biologics, have potencies that are based on “__________” and are expressed in terms of “________________”
activity; units of activity
49
COMPOUNDING WITH POTENCY-DESIGNATED INGREDIENTS T/F: There is a relationship between the units of potency of one drug with another different drug
F - no relationship
50
COMPOUNDING WITH POTENCY-DESIGNATED INGREDIENTS What is the basis of potency determination?
dried or anhydrous basis
51
COMPOUNDING WITH POTENCY-DESIGNATED INGREDIENTS Antibiotics potency is expressed as _________________________
mcg of activity per mg of substance
52
COMPOUNDING WITH POTENCY-DESIGNATED INGREDIENTS in drugs like heparin and insulin, the actual dose may be expressed in ________, instead of mg
units
53
LABELLING OF POTENCY-DESIGNATED INGREDIENTS Each container must be labeled with the _________________, and this information is to be used in calculations involving dosing prior to compounding
actual potency
54
COMPOUNDING WITH COMPLEX ORGANIC MOLECULES identified as the most complex molecules and biotechnology products
proteins
55
COMPOUNDING WITH COMPLEX ORGANIC MOLECULES proteins are inherently _________________ molecules and require special handling, and their ________________ profiles can be quite complex
unstable; degradation
56
COMPOUNDING WITH COMPLEX ORGANIC MOLECULES pharmacists should be knowledgable on the protein's ________________, _________________, and _______________ to the site of action
stabilization, formulation, and delivery
57
COMPOUNDING WITH COMPLEX ORGANIC MOLECULES Protein drugs are ________________ and are used in quite _____________________________
very potent; low concentrations
58
COMPOUNDING WITH COMPLEX ORGANIC MOLECULES T/F: The bulk of compounded protein preparations may be the excipients, including the vehicle, buffers and stabilizers
T
59
COMPOUNDING WITH COMPLEX ORGANIC MOLECULES In TPN’s containing Calcium and Phosphate salts can form precipitate with proteins ________________
less than 6%
60
What are the factors to be considered when compounding with complex organic molecules?
1. pH 2. chelating agents 3. antioxidants 4. preservatives 5. stabilizers and tonicity-adjusting agents
61
What is the key to formulating a stable preparation?
pH
62
What are used to obtain optimal pH range?
physiologic buffers
63
COMPOUNDING WITH COMPLEX ORGANIC MOLECULES T/F: An increase in buffer concentration indicates decrease in pain on injection
F - increase in pain
64
Purpose of adding chelating agents in preparations
1. to bind trace metals, like copper, iron, calcium and manganese 2. to minimize rates of degradation
65
Example of chelating agent
EDTA (0.01-0.05%)
66
incorporated to prevent protein degradation due to oxidation
antioxidants
67
Examples of antioxidants
ascorbic acid, sodium disulfide, a-tocopherol (0.05-0.1%)
68
T/F: Preservatives may be required, especially if multiple dose vials are prepared.
T
69
phenol, chlorobutanol and benzyl alcohol are examples of
preservatives
70
Example of stabilizer
polyols at 1-10%
71
Example of tonicity-adjusting agents
sodium chloride and dextrose
72
COMPOUNDING WITH COMMERCIAL PRODUCTS commonly used to prepare oral liquids (solutions and suspensions) for pediatric use
oral tablets and capsules
73
COMPOUNDING WITH COMMERCIAL PRODUCTS used to prepare intravenous admixtures
injectable drugs
74
T/F: Use of commercial products as source of API usually result in lower prescription cost
F - higher prescription cost
75
Uncertainties in compounding involve the presence of __________________ and ____________________
excipients and actual assay potency
76
presence of ____________ in the commercial drug product may influence and dictate the _____ of the final compounded preparation
buffers; pH
77
This type of dosage form should not be used in compounding unless it has been indicated or documented that they can be used
modified-release dosage forms (e.g., extended-release, delayed-release, repeat-action and targeted release)
78
Important things to note when using commercial products in compounding
list the... 1. manufacturer 2. lot number 3. expiration date and, 4. assign the BUD based on the product stability and insert
79
What are the basis of the most appropriate method for medication disposal?
1. government regulations 2. environmental impact 3. type, volume, and toxicity of medication 4. setting and risk of diversion
80
What is the optimal method of medication disposal?
incineration
81
What are the types of pharmaceutical waste?
1. hazardous waste 2. regulated medical waste 3. universal waste 4. controlled substance waste 5. non-hazardous medical waste
82
Types of hazardous wastes
1. ignitable 2. corrosive 3. reactive 4. toxic
83
DETERMINE WHAT TYPE OF WASTE aqueous drug formulations containing >24% alcohol by volume
hazardous - ignitable waste
84
DETERMINE WHAT TYPE OF WASTE oxidizers or materials that readily supply oxygen to a reaction in the absence of air (e.g. AgNO3 applicators)
hazardous - ignitable waste
85
DETERMINE WHAT TYPE OF WASTE flammable aerosol propellants
hazardous - ignitable waste
86
DETERMINE WHAT TYPE OF WASTE agents with pH <2 or >12.5
hazardous - corrosive waste
87
DETERMINE WHAT TYPE OF WASTE glacial acetic acid, NaOH
hazardous - corrosive waste
88
DETERMINE WHAT TYPE OF WASTE heavy metals like barium, selenium and thimerosal
hazardous - toxic waste
89
DETERMINE WHAT TYPE OF WASTE biohazardous waste or infectious medical waste
regulated medical waste
90
DETERMINE WHAT TYPE OF WASTE waste contaminated by blood, body fluids, or other potentially infectious material, including sharps
regulated medical waste
91
DETERMINE WHAT TYPE OF WASTE commonly generated hazardous waste (e.g., batteries, pesticides, mercury-containing products and bulbs/lamps)
universal waste
92
DISPOSAL OF MEDICATION WASTE ASHP recommends that healthcare facilities have a ____________________ waste management team
multidisciplinary
93
DISPOSAL OF MEDICATION WASTE _________________ must be incinerated at an EPA-approved facility
Hazardous waste
94
What does EPA stand for?
Environmental Protection Agency
95
DISPOSAL OF MEDICATION WASTE ________________________________ should be disposed of in a medical waste or municipal incinerator
nonhazardous pharmaceutical waste
96
T/F: Do not flush medications unless otherwise stated
T
97
T/F: When disposal programs are not available, do not throw away unwanted medications in the trash.
F - throw away unwanted medications in the trash using appropriate safeguards
98
Topical patches should be folded in _____, _______________, and should remain intact
half, adhesive in
99
Mix the medications with ___________________, like used coffee grounds, sawdust, or kitty litter to make them less appealing to children and animals
undesirable substance
100
T/F: Throw away medication container in household trash
T